Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Meghmani Finechem Limited submits herewith copy of advertisement published on January 25, 2022 in Financial Express (English and Gujarati) for Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2021. Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meghmani Finechem Limited ("Company") hereby informs that the Senior Management Team of the Company is having One-on-one meeting with: Name: White Pine Investment Management Date: Thursday, 3rd February, 2022 Meeting Type : One-on-one Meeting at Plant situated at Dahej, District Bharnch, Gujarat. Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meghmani Finechem Limited ('Company') hereby informs that the Senior Management Team of the Company is having Group Video Call meeting with: Name : 1. Aditya Birla Money Limited 2. VEC Investments LLC Date : Monday, 31st January, 2022 Meeting Type : Group Video Call Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meghmani Finechem Limited ("Company") hereby informs that the Senior Management Team of the Company is having One-on-one meeting with Mission Holdings on 29th January, 2022 at Plant situated at Dahej, District Bharuch, Gujarat.
Earnings Call for Q3FY22 of Meghmani Finechem
Conference Call with Meghmani Finechem Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript. Q3FY22 Quarterly Result Announced for Meghmani Finechem Ltd.
Specialty Chemicals company Meghmani Finechem declares Q3FY22 result: Revenue up by 85% to Rs 1052 Cr on YoY, backed by increase in volume, higher utilization and higher realisation for all the products EBITDA increased by 85% to Rs 334 Cr on YoY; margins maintained at 32% despite surge in raw material prices ROCE improved to 26% as on 9MFY22 due to higher profitability backed by improved realization in all products and contribution from new capacities of Hydrogen Peroxide and Caustic Soda Revenue up by 91% to Rs 422 Cr backed by increase in revenue of Chlor-Alkali and Derivatives by 104% and 59% respectively EBITDA increased by 107% to Rs 141 Cr and EBITDA margin was up by 260 bps to 33.5%, despite high inflationary pressure on raw materials PAT increased by 184% to Rs 70 Cr and PAT margin was up by 540 bps to 16.5% Commenting on the results Mr Maulik Patel; Chairman and Managing Director - MFL said: We are glad to report a good performance during the quarter. We have achieved the highest ever topline for 9 months of Rs 1,052 Cr. The commissioning and optimal utilisation of CMS & H2O2 drove our revenue & profit growth. The investments undertaken in the last couple of years for diversification of products continue to drive growth and increase our competitiveness. The forward & backward integration expansion plan covering ECH, CPVC, Caustic soda and Captive power is progressing as per plan and will be commissioned as per schedule. We are simultaneously ensuring a sound financial, healthy cash generation and strong liquidity to ensure that we continue to meet all our obligations and commitments timely Further in line for continuous growth we have announced our expansion in Chlorotoluene & its value chain and setting up R&D; facility, this will help to further strengthen our fully integrated complex. We continue to move forward in our strategic direction of scalability, strengthening integration & achieving lowest cost of operations. Result PDF Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Investor Presentation
Meghmani Finechem Limited (MFL) submits herewith Q3 FY 22 Earnings Presentation. Meghmani Finechem Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Meghmani Finechem Limited (MFL) submits herewith Press release for Unaudited Financial Results of Q3 FY22. Meghmani Finechem Ltd - 543332 - Results - Unaudited Financial Results For The Quarter Ended On 31.12.2021
We wish to inform you that the Board of Directors of the Company at its meeting held on 24th January, 2022, has inter-alia, considered and approved : Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Un Audited Financial Results (Consolidated & Standalone) of the Third Quarter & Nine Months ended on 31st December, 2021 reviewed by Audit Committee and approved by Board of Directors at their meeting held today i.e. on 24th January, 2022 is forwarded herewith. The Statutory Auditors M/s S R B C & CO LLP, Chartered Accountants have also carried out a limited review Report on Un-audited Financial Results (Consolidated & Standalone) of the Third Quarter & Nine Months ended 31st December, 2021 and the same is also forwarded herewith. Meghmani Finechem Ltd - 543332 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 24Th January, 2022
We wish to inform you that the Board of Directors of the Company at its meeting held on 24th January, 2022, has inter-alia, considered and approved : 1. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Un Audited Financial Results (Consolidated & Standalone) of the Third Quarter & Nine Months ended on 31st December, 2021 reviewed by Audit Committee and approved by Board of Directors at their meeting held today i.e. on 24th January, 2022 is forwarded herewith. The Statutory Auditors M/s S R B C & CO LLP, Chartered Accountants have also carried out a limited review Report thereon. 2. The Shifting of the registered office of the Company from District Bharuch to District Ahmedabad, within the State of Gujarat subject to approval of shareholders. The Draft Notice of Postal Ballot along with the explanatory statement was also approved.